연구동향 분석

Changes in Plasma Levels of Natural Anticoagulants in Disseminated Intravascular Coagulation: High Prognostic Value of Antithrombin and Protein C in Patients with Underlying Sepsis or Severe Infection

최규태 홍기호 김지은 김현경 2014년

논문상세정보
인용/피인용
' Changes in Plasma Levels of Natural Anticoagulants in Disseminated Intravascular Coagulation: High Prognostic Value of Antithrombin and Protein C in Patients with Underlying Sepsis or Severe Infection' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • antithrombin
  • disseminated intravascular coagulation
  • naturalanticoagulant
  • protein s
  • proteinc
  • proteinz
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,607 0

0.0%

' Changes in Plasma Levels of Natural Anticoagulants in Disseminated Intravascular Coagulation: High Prognostic Value of Antithrombin and Protein C in Patients with Underlying Sepsis or Severe Infection' 의 참고문헌

  • Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response
    Taylor FB Crit Care Med 29 326-334 [2001]
  • Thrombin-dependent NF-κB activation and monocyte/endothelial adhesion are mediated by the CARMÁ3·Bcl10·MALT signalosome
    Delekta PC J Biol Chem 285 41432-41442 [2010]
  • Severe protein C deficiency predicts early death in severe sepsis
    Macias WL Crit Care Med 32 223-228 [2004]
  • Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies
    Fourrier F Chest 101 816-823 [1992]
  • Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition,clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation
    Taylor FB Jr Thromb Haemost 86 1327-1330 [2001]
  • Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation
    Maruyama I Thromb Haemost 82 718-721 [1999]
  • Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis
    Corral J Br J Haematol 137 99-108 [2007]
  • Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis
    Al-Shanqeeti A Thromb Haemost 93 411-413 [2005]
  • Protein C anticoagulant system--anti-inflammatory effects
    Esmon CT Semin Immunopathol 34 127-132 [2012]
  • Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases
    Kawasugi K Thromb Res 128 186-190 [2011]
  • Plasma antithrombin III and protein C levels in early recognition of late-onset sepsis in newborns
    Lauterbach R Eur J Pediatr 165 585-589 [2006]
  • Low plasma protein Z levels in patients with antiphospholipid antibodies
    Steffano B Blood Coagul Fibrinolysis 12 411-412 [2001]
  • Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis
    Kim SY BLOOD COAGULATION & FIBRINOLYSIS 24 150-156 [2013]
  • Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
    Levi M Br J Haematol 145 24-33 [2009]
  • Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness
    Sawamura A Clin Appl Thromb Hemost 15 561-566 [2009]
  • Disseminated intravascular coagulation
    Levi M N Engl J Med 341 586-592 [1999]
  • Diagnostic criteria and laboratory tests for disseminated intravascular coagulation
    Kaneko T J Clin Exp Hematop 51 67-76 [2011]
  • Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation
    Chung S Thromb Res 125 285-293 [2010]